Lorberbaum, Tal
Sampson, Kevin J.
Woosley, Raymond L.
Kass, Robert S.
Tatonetti, Nicholas P.
Funding for this research was provided by:
National Institute of General Medical Sciences (T32GM082797, R01GM107145, R01GM107145)
National Institutes of Health (5R01GM109762-02, 5R01GM109762-02)
Article History
First Online: 10 February 2016
Compliance with Ethical Standards
: This study was approved by the CUMC Institutional Review Board.
: Tal Lorberbaum is supported by a training grant from the National Institute of General Medical Sciences (T32GM082797); Tal Lorberbaum and Nicholas P. Tatonetti are supported by the National Institute of General Medical Sciences (R01GM107145); and Kevin J. Sampson and Robert S. Kass are supported by the National Institute of Health (5R01GM109762-02).
: Tal Lorberbaum, Kevin J. Sampson, and Robert S. Kass declare that they have no conflicts of interest. Nicholas P. Tatonetti is a paid advisor to Advera Health, Inc.; he declares no conflicts of interest. Raymond L. Woosley is an uncompensated officer of the non-profit organization AZCERT.org, which is supported by FDA HHSF223201400189C and which maintains the websiteutilized in this study; he declares no conflicts of interest.